Baxter Gross Margin 2010-2024 | BAX

Current and historical gross margin for Baxter (BAX) over the last 10 years. The current gross profit margin for Baxter as of December 31, 2024 is %.
Baxter Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-12-31 $10.64B $3.98B 37.46%
2024-09-30 $10.64B $4.56B 42.83%
2024-06-30 $10.54B $4.58B 43.46%
2024-03-31 $10.44B $4.26B 40.83%
2023-12-31 $10.36B $4.15B 40.06%
2023-09-30 $8.97B $3.23B 35.99%
2023-06-30 $9.98B $3.22B 32.24%
2023-03-31 $9.86B $3.48B 35.24%
2022-12-31 $10.06B $3.55B 35.29%
2022-09-30 $13.79B $4.79B 34.71%
2022-06-30 $13.40B $5.06B 37.76%
2022-03-31 $12.91B $4.92B 38.14%
2021-12-31 $12.15B $4.72B 38.86%
2021-09-30 $12.45B $4.89B 39.27%
2021-06-30 $12.20B $4.76B 39.06%
2021-03-31 $11.82B $4.57B 38.66%
2020-12-31 $11.67B $4.59B 39.30%
2020-09-30 $11.53B $4.69B 40.71%
2020-06-30 $11.41B $4.73B 41.45%
2020-03-31 $11.53B $4.84B 42.03%
2019-12-31 $11.36B $4.76B 41.90%
2019-09-30 $11.14B $4.64B 41.62%
2019-06-30 $11.05B $4.64B 41.97%
2019-03-31 $11.06B $4.73B 42.72%
2018-12-31 $11.10B $4.76B 42.88%
2018-09-30 $11.08B $4.75B 42.91%
2018-06-30 $11.02B $4.65B 42.19%
2018-03-31 $10.79B $4.54B 42.13%
2017-12-31 $10.58B $4.47B 42.27%
2017-09-30 $10.43B $4.41B 42.31%
2017-06-30 $10.28B $4.36B 42.35%
2017-03-31 $10.26B $4.20B 40.87%
2016-12-31 $10.16B $4.12B 40.50%
2016-09-30 $10.12B $4.08B 40.31%
2016-06-30 $10.05B $4.04B 40.23%
2016-03-31 $9.94B $4.09B 41.17%
2015-12-31 $9.97B $4.15B 41.59%
2015-09-30 $10.15B $4.28B 42.16%
2015-06-30 $10.38B $4.44B 42.79%
2015-03-31 $12.06B $5.39B 44.70%
2014-12-31 $13.50B $6.26B 46.37%
2014-09-30 $15.03B $7.05B 46.89%
2014-06-30 $16.03B $7.76B 48.41%
2014-03-31 $15.55B $7.73B 49.73%
2013-12-31 $15.15B $7.60B 50.15%
2013-09-30 $14.33B $7.34B 51.23%
2013-06-30 $14.09B $7.24B 51.39%
2013-03-31 $14.00B $7.18B 51.27%
2012-12-31 $13.94B $7.13B 51.19%
2012-09-30 $14.03B $7.16B 51.04%
2012-06-30 $14.03B $7.12B 50.75%
2012-03-31 $14.00B $7.09B 50.62%
2011-12-31 $13.89B $7.05B 50.72%
2011-09-30 $13.80B $6.90B 50.00%
2011-06-30 $13.54B $6.79B 50.12%
2011-03-31 $13.20B $6.59B 49.92%
2010-12-31 $12.84B $5.96B 46.39%
2010-09-30 $12.82B $6.11B 47.66%
2010-06-30 $12.74B $6.08B 47.74%
2010-03-31 $12.67B $6.08B 48.01%
2009-12-31 $12.56B $6.53B 51.94%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.557B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.058B 28.41
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
Agilent Technologies (A) United States $33.351B 22.03
ResMed (RMD) United States $32.876B 25.32
Terumo (TRUMY) Japan $27.805B 39.54
Koninklijke Philips (PHG) Netherlands $23.874B 17.05
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AtriCure (ATRC) United States $1.577B 0.00
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.087B 12.18
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00